Literature DB >> 8180102

Growth factors and steroid hormone action in endometrial cancer.

L J Murphy1.   

Abstract

There is compelling evidence that growth factors are involved in mediating estrogen action in target tissues. The role of growth factors in the development and progression of endometrial cancer is less clear. Steroid hormones can regulate the expression of the transforming growth factors and epidermal growth factor receptors in endometrial cancer cells in culture. It is also possible to demonstrate that these growth factors function in an autocrine fashion to regulate proliferation of endometrial cancer cells in culture. Constitutive expression or overexpression of such autocrine/paracrine factors and/or their receptors may be important in the growth progression of endometrial neoplasia. However, to date the evidence to support the hypothesis is limited.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8180102     DOI: 10.1016/0960-0760(94)90189-9

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  7 in total

1.  Disorders of intraorganismal systemic communications during carcinogenesis.

Authors:  I P Shabalkin; V I Minaev; P I Shabalkin; A S Yagubov
Journal:  Dokl Biol Sci       Date:  2000 Nov-Dec

2.  Diabetes mellitus and risk of endometrial cancer: a meta-analysis.

Authors:  E Friberg; N Orsini; C S Mantzoros; A Wolk
Journal:  Diabetologia       Date:  2007-05-03       Impact factor: 10.122

3.  The Influence of the Metabolic Syndrome on Early Postoperative Outcomes of Patients With Advanced-stage Endometrial Cancer.

Authors:  Nicolae Bacalbasa; Camelia Diaconu; Laura Iliescu; Cornel Savu; Carmen Savu; Cristian Balalau; Mihai Dimitriu; Alexandru Filipescu; Ovidiu Gabriel Bratu; Adrian Neacsu; Dragos Cretoiu; Ioana Halmaciu; Irina Balescu
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

4.  Coffee drinking and risk of endometrial cancer--a population-based cohort study.

Authors:  Emilie Friberg; Nicola Orsini; Christos S Mantzoros; Alicja Wolk
Journal:  Int J Cancer       Date:  2009-11-15       Impact factor: 7.396

5.  Alcohol intake and endometrial cancer risk: a meta-analysis of prospective studies.

Authors:  E Friberg; N Orsini; C S Mantzoros; A Wolk
Journal:  Br J Cancer       Date:  2010-05-18       Impact factor: 7.640

6.  Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells.

Authors:  G E Konecny; N Venkatesan; G Yang; J Dering; C Ginther; R Finn; M Rahmeh; M Schoenberg Fejzo; D Toft; S-W Jiang; D J Slamon; K C Podratz
Journal:  Br J Cancer       Date:  2008-03-11       Impact factor: 7.640

7.  Evidence of a Causal Association Between Insulinemia and Endometrial Cancer: A Mendelian Randomization Analysis.

Authors:  Kevin T Nead; Stephen J Sharp; Deborah J Thompson; Jodie N Painter; David B Savage; Robert K Semple; Adam Barker; John R B Perry; John Attia; Alison M Dunning; Douglas F Easton; Elizabeth Holliday; Luca A Lotta; Tracy O'Mara; Mark McEvoy; Paul D P Pharoah; Rodney J Scott; Amanda B Spurdle; Claudia Langenberg; Nicholas J Wareham; Robert A Scott
Journal:  J Natl Cancer Inst       Date:  2015-07-01       Impact factor: 13.506

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.